Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
HTL Biotechnology’s first symposium at the congress was a resounding success. With a focus on collagen, DNA, and regenerative medicine, we had the opportunity to showcase our cutting-edge technologies, which participants found particularly innovative.
The connections established during the congress promise a bright future for these solutions and reflect growing interest in our expertise.
This first edition confirmed the importance of HTL Biotechnology’s presence at such a prominent event, paving the way for future collaborations and developments.
HTL Biotechnology made a strong impact this year at IMCAS with a reinforced presence and exciting interactions with our customers and partners.
We’re happy to share that HTL Biotechnology got the new certification ISO 13485.
We’re excited to announce the publication of our first CSR Report!